PROGRESSIVE DECLINE OF HBSAG TITERS IN LONG-TERM VIROLOGICAL RESPONDERS TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B

被引:0
|
作者
Iavarone, Massimo
Lampertico, Pietro
Vigano, Mauro
Facchetti, Floriana
Melotti, Silvia [1 ]
Lunghi, Giovanna [1 ]
Colombo, Massimo
机构
[1] Univ Milan, Maggiore Hosp, Cent Lab, Milan, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
900
引用
收藏
页码:709A / 709A
页数:1
相关论文
共 50 条
  • [21] LONG-TERM KINETICS OF HEPATITIS B SURFACE ANTIGEN (HBSAG) DURING NUCLEOS(T)IDE ANALOGUE THERAPY INDICATE THAT FINITE TREATMENT IS UNLIKELY
    Chevaliez, Stephane
    Hezode, Christophe
    Bahrami, Stephane
    Grare, Marion
    Pawlotsky, Jean-Michel
    HEPATOLOGY, 2011, 54 : 1082A - 1082A
  • [22] HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapy
    Barone, Michele
    Iannone, Andrea
    Di Leo, Alfredo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (26) : 8722 - 8725
  • [23] Adherence to nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B
    Manolakopoulos, Spilios
    Goulis, John
    Striki, Athanasia
    Deutsch, Melanie
    Perlepe, Nikoleta
    Triantos, Christos
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2015, 148 (04) : S1068 - S1068
  • [24] Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long-term nucleos(t)ide analogue therapy
    Hsu, Wei-Fan
    Chen, Chuen-Fei
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Chen, Sheng-Hung
    Chen, Ching-Hsiang
    Wang, Hung-Wei
    Huang, Guan-Tarn
    Peng, Cheng-Yuan
    LIVER INTERNATIONAL, 2018, 38 (04) : 627 - 635
  • [25] KINETICS OF QUANTITATIVE HBsAg DECLINE IN CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS( T) IDE ANTIVIRAL THERAPY
    Hyun, Yong Gyu
    Fung, Scott K.
    HEPATOLOGY, 2023, 78 : S432 - S433
  • [26] INCIDENCE FOR LOSS-TO-FOLLOW-UP IN PATIENTS WITH CHRONIC HEPATITIS B DURING LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY
    Su Chung-Wei
    Yen-Chun Liu
    Chien-Wei Peng
    Wen-Juei Jeng
    Rong-Nan Chien
    Yun-Fan Liaw
    HEPATOLOGY, 2022, 76 : S289 - S290
  • [27] Discontinuation of long-term Nucleos(t)ide analogue therapy before HBsAg loss in HBeAg negative CHB patients: follow-up of long-term responders
    Petersen, Joerg
    Hansen, Bettina E.
    Buggisch, Peter
    Hinrichsen, Holger
    Berg, Thomas
    Wedemeyer, Heiner
    Stoehr, Albrecht
    Chan, Henry Lik-Yuen
    Arends, Pauline
    Wiegand, Steffen B.
    Brunetto, Maurizia R.
    Cornberg, Markus
    Janssen, Harry L.
    HEPATOLOGY, 2013, 58 : 680A - 681A
  • [28] Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Petersen, Joerg
    Buti, Maria
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 683 - 694
  • [29] Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
    Chang, M. -L.
    Liaw, Y. -F.
    Hadziyannis, S. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (03) : 243 - 257
  • [30] Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
    Lai, Ching-Lung
    Wong, Danny
    Ip, Philip
    Kopaniszen, Malgorzata
    Seto, Wai-Kay
    Fung, James
    Huang, Fung-Yu
    Lee, Brian
    Cullaro, Giuseppe
    Chong, Chun Kong
    Wu, Ringo
    Cheng, Charles
    Yuen, John
    Ngai, Vincent
    Yuen, Man-Fung
    JOURNAL OF HEPATOLOGY, 2017, 66 (02) : 275 - 281